Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
VISTAPH.BOthis companyVista Pharmaceuticals Limited	₹6.69	-3.12×	1.03×	6.96×	-3.32×	-1006.0%	-51.3%	-284.6%	-223.4%	-33.1%	-24.6%	-16.7%	0.27×	-0.69×	-13.96×	0.92×	0.0%	2	0.4	1	D+
CHOKSI.BOChoksi Asia Limited	₹202.95	12.92×	1.64×	1.4×	9.46×	-1881.5%	17.9%	13.2%	10.8%	12.7%	10.4%	-0.2%	0.05×	-0.68×	15.37×	6.67×	0.0%	4	15.2	1	C-
CONCORD.BOConcord Drugs Limited	₹72.72	83.11×	1.8×	1.11×	22.15×	-217.1%	14.1%	4.0%	1.3%	2.2%	3.5%	-9.1%	0.28×	2.93×	1.86×	2.53×	0.0%	4	—	2	C
GODAVARI.BOGodavari Drugs Limited	₹121.00	15.84×	0.85×	0.61×	12.28×	-172.8%	19.1%	7.4%	3.9%	5.4%	4.1%	-46.3%	1.01×	6×	1.98×	1.31×	0.0%	2	—	2	C+
LALASA.BOLasa Supergenerics Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
LASA.NSLasa Supergenerics Limited	₹4.22	-0.83×	0.57×	1.13×	-1.34×	-306.6%	-27.4%	-53.2%	-135.6%	-68.7%	-22.1%	0.0%	0.2×	-0.34×	-34.66×	0.62×	0.0%	2	—	2	C
Peer median	—	14.38×	1.25×	1.12×	10.87×	-261.9%	16.0%	5.7%	2.6%	3.8%	3.8%	-4.6%	0.24×	1.3×	1.92×	1.92×	0.0%	3	15.2	2	—